A BREAKTHROUGH IN THE TREATMENT OF PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: THE CLINICAL SIGNIFICANCE OF THE PARADIGM HF-TRIAL ArticleКобалава Ж.Д., Виллевальде С.В., Лукина О.И.Kardiologiia. Vol. 57. 2017. P.. 76-82
PREVALENCE OF MARKERS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION: RESULTS OF EPIDEMIOLOGICAL STUDY CHRONOGRAF ArticleКобалава Ж.Д., Виллевальде С.В., Боровкова Н.Ю., Шутов А.М., Ничик Т.Е., Сафуанова Г.Ш.Kardiologiia. Vol. 57. 2017. P.. 39-44
РАСПРОСТРАНЕННОСТЬ МАРКЕРОВ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ И САХАРНЫМ ДИАБЕТОМ В РЕАЛЬНОЙ ПРАКТИКЕ ArticleКулаков В.В., Виллевальде С.В., Кобалава Ж.Д.Трудный пациент. Vol. 15. 2017. P.. 49-53
ЛЕВОЖЕЛУДОЧКОВО-АРТЕРИАЛЬНОЕ СОПРЯЖЕНИЕ КАК РАННИЙ МАРКЕР НЕБЛАГОПРИЯТНОГО РЕМОДЕЛИРОВАНИЯ СЕРДЦА У ПАЦИЕНТОВ, ПЕРЕНЕСШИХ ИНФАРКТ МИОКАРДА ArticleЖарикова Е.С., Виллевальде С.В., Кобалава Ж.Д.Клиническая фармакология и терапия. Vol. 26. 2017. P.. 12-16
PREDICTORS OF ADVERSE LEFT VENTRICULAR REMODELING IN PATIENTS AFTER MYOCARDIAL INFARCTION ArticleЖарикова Е.С., Виллевальде С.В., Кобалава Ж.Д.Вестник Российского университета дружбы народов. Серия: Медицина. Vol. 21. 2017. P.. 219-226
(-75)G ALLELE OF APOA1 GENE IS ASSOCIATED WITH NON-ATTAINMENT OF TARGET LIPID LEVELS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS ArticleVorobyeva M., Gigani O., Azova M., Villevalde S., Kobalava Z.European Journal of Heart Failure. Vol. Vol19. 2017. P.. 159-159
MONOCYTE CHEMOATTRACTANT PROTEIN-1 LEVEL AND (-75)G/A POLYMORPHISM OF APOA1 GENE PREDICT RESPONSE AND RESISTANCE TO INTENSIVE STATIN THERAPY IN VERY HIGH CARDIOVASCULAR RISK PATIENTS ArticleVorobyeva M., Gigani O., Villevalde S., Azova M., Kobalava Z.European Heart Journal. Vol. Vol38. 2017.
CARDIORENOHEPATIC SYNDROME IS COMMON IN PATIENTS WITH DECOMPENSATED HEART FAILURE ArticleSoloveva A., Villevalde S., Kobalava Z.European Journal of Heart Failure. Vol. Vol19. 2017. P.. 446-446
LIVER STIFFNESS ASSESSED BY TRANSIENT ELASTOGRAPHY IS ASSOCIATED WITH CONGESTION IN PAPIENTS WITH DECOMPENSATED HEART FSILURE ArticleSoloveva A., Bayarsaikhan M., Garmash I., Villevalde S., Kobalava Z.European Journal of Heart Failure. Vol. Vol19. 2017. P.. 265-265
CARDIOHEPATIC SYNDROME IS DRIVEN BY CONGESTION RATHER THAN HYPOPERFUSION IN DECOMPENSATED HEART FAILURE ArticleSoloveva A., Villevalde S., Kobalava Z.European Journal of Heart Failure. Vol. Vol19. 2017. P.. 96-96
PENDING HEART FAILURE CLINIC OPENING: CARE PERFORMANCE MEASURES IN REAL-LIFE PRACTICE ArticlePadaryan S., Galochin S., Soseliya N., Shavarova E., Villevalde S., Milto A., Kobalava Z.European Journal of Heart Failure. Vol. Vol19. 2017. P.. 410-410
PREDICTORS OF SIX-MONTH MORTALITY AFTER DISCHARGE IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CHRONIC HEART FAILURE ArticleGalochin S., Padaryan S., Babaeva L., Shavarova E., Villevalde S., Kobalava Z.European Journal of Heart Failure. Vol. Vol19. 2017. P.. 486-486
MIXED PHENOTYPE OF CARDIOHEPATIC SYNDROME IS COMMON AND ASSOCIATED WITH WORSE PROGNOSIS IN PATIENTS WITH DECOMPENSATED HEART FAILURE ArticleSoloveva A., Villevalde S., Kobalava Z.European Journal of Heart Failure. Vol. Vol19. 2017. P.. 97-97
HIGH PREVALENCE OF MASKED ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS ArticleTroitskaya E., Velmakin S., Villevalde S., Kobalava Z.European Journal of Heart Failure. Vol. Vol19. 2017. P.. 101-101
BASELINE KIDNEY FUNCTION AND BLOOD PRESSURE LEVEL ARE MAIN PREDICTORS OF ACUTE KIDNEY INJURY IN PATIENTS ADMITTED WITH CARDIAC DISEASES ArticleEfremovtseva M., Villevalde S., Kobalava Z., Avdishina S.Journal of Hypertension. Vol. 35. 2017.